Author: Abhay Panchal

Colorectal cancer (CRC) is a major public health concern, emphasizing the importance of early detection and refining current screening methods. This systematic review aimed to evaluate the advantages and drawbacks of AI-based computer-aided detection (CADe) systems compared to standard colonoscopy. The review highlights the global prevalence and mortality rates of CRC and the challenges of undetected adenomas and polyps. It summarizes findings from 13 randomized controlled trials (RCTs) from 2019 to 2023, assessing the impact of CADe on polyp and adenoma detection. The results consistently indicate that CADe outperforms traditional colonoscopy in terms of adenoma detection rate (ADR) and polyp…

Read More

Researchers at Penn Medicine are delving into the potential of conversational AI tools like ChatGPT in the medical field. Here’s a summary of the article: ChatGPT in Medicine: When asked about its role in medicine, ChatGPT provides a detailed explanation of its potential applications in healthcare. However, researchers at Penn, including Samiran Mukherjee, MBBS, chief fellow in Gastroenterology at the Perelman School of Medicine, are actively studying it. AI’s Role in Healthcare: Mukherjee believes that AI technology is here to stay. He emphasizes the importance of understanding how medical professionals can leverage it and how patients might interact with it.…

Read More

Value-based care, which emphasizes patient outcomes and cost-effectiveness over traditional fee-for-service models, is becoming a prominent topic in healthcare. When it comes to Ambulatory Surgery Centers (ASCs), three healthcare leaders shared their insights: Jitander Dudee, MD, Surgeon at Medical Vision Institute (Lexington, Ky.): Dudee believes that ASCs are primed to thrive in a value-based care environment due to their capacity to provide high-quality, cost-effective care. He suggests that ASC leaders should focus on enhancing patient experiences, refining operational efficiency, and showcasing tangible value to payers and stakeholders. Ahmed Elsahy, MD, Anesthesiologist at IU Health University Hospital Interventional & Advanced Pain…

Read More

Yale researchers are delving into the potential applications of artificial intelligence (AI) in healthcare. Harlan Krumholz, a professor of medicine at the School of Medicine, envisions a future where healthcare extends beyond clinics, with wearable devices collecting vital health data and AI algorithms analyzing this data for early diagnosis. Recent studies from Yale have showcased the potential of AI in healthcare, including an algorithm that diagnoses aortic stenosis from an echocardiogram and another that predicts COVID-19 outcomes for emergency room patients within 12 hours. However, concerns arise regarding the reliability and ethics of AI in healthcare. The vast amount of…

Read More

There is a relatively new device that was recently FDA-approved for chronic idiopathic constipation, and that’s the vibrating capsule. I think some of you may be aware of this device. So it’s a device that is FDA-approved for five times a week and is activated twice. So typically, you take it in the evening, and it activates around noon the next day, and then 6 p.m. that same day, each for 2 hours’ time. In phase 3 clinical trials, it did significantly improve the number of complete spontaneous bowel movements per week, which was statistically significant over the sham device.…

Read More

Google has committed to funding 15 AI-driven projects that aim to enhance the provider experience and patient access to care, aligning with the United Nations Sustainable Development Goals. Each of these projects will receive $3 million in the form of technical assistance, cash, and Google Cloud credits. Some projects will also benefit from Google.org Fellowships, where Google employees collaborate with an organization on a pro bono basis for up to half a year. Out of the 15 projects, eight are digital health initiatives:

Read More

A study published in Gastroenterology demonstrated that the TissueCypher® Barrett’s Esophagus test, developed by Castle Biosciences, Inc., surpassed the standard of care pathology review in predicting the progression to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) in patients with Barrett’s esophagus (BE) initially diagnosed with low-grade dysplasia (LGD). The study involved 154 BE patients and compared the test’s performance against a panel of expert and community-based pathologists. TissueCypher showed higher sensitivity in detecting patients progressing to HGD/EAC. The test uses Artificial Intelligence to provide objective information about a patient’s risk of progressing to esophageal cancer. Key Insights:

Read More

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Limaca Medical for its Precision GI endoscopic ultrasound biopsy device. This clearance follows the device’s breakthrough designation in May 2022. The Precision GI device is designed to obtain biopsies for diagnosing pancreatic and gastrointestinal cancers. Initial patient trials have shown that the device can obtain contiguous intact core tissue samples that are adequate for definitive diagnoses of pancreatic lesions. The device’s design features a unique motorized, automated rotational cutting needle, which offers advantages over manual hand-operated biopsy devices. The Precision GI device has demonstrated faster tissue sampling times…

Read More